Skip to content

Beta-alanine Supplementation and CrossFit Performance

Examining the Effects of 3-weeks Beta-Alanine Supplementation on CrossFit® Performance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05772988
Enrollment
12
Registered
2023-03-17
Start date
2023-03-15
Completion date
2023-08-31
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-Induced Lactic Acidemia

Brief summary

This study will randomize CrossFit participants to receive beta-alanine or placebo supplementation for 3 weeks. The study will be double-blind. Performance on the Fran test will be completed at baseline and after the 3 week intervention. Respiratory exchange ratio will also be assessed during the performance test at baseline and after 3 weeks.

Detailed description

Beta-alanine is a nutritional supplement often consumed by people involved in high-intensity sports that involve substantial lactic acidosis. If consumed on a regular basis, it improves muscle buffering capacity and exercise performance during high-intensity moderate-duration events. CrossFit involves competitions that are high in intensity and moderate duration and many elite CrossFit athletes have reported taking beta-alanine as a supplement. It has never however been evaluated in a research study for its affect on CrossFit performance. The purpose of the study is therefore to assess the effects of beta-alanine supplementation on CrossFit performance. A maximum of 30 CrossFit participants will participate in this randomized double-blind parallel groups study. Participants will be randomized to receive 6.4 g/d beta-alanine or maltodextrin placebo for 3 weeks. At baseline and after the intervention, participants will complete a Fran test, which involves performing sets of repeated dumbbell thrusters alternating with chin-ups. The performance measure is the time to complete the test. During the test, respiratory exchange ratio will be assessed to indirectly assess acidosis.

Interventions

DIETARY_SUPPLEMENTBeta-alanine

Beta-alanine

DIETARY_SUPPLEMENTMaltodextrin

Maltodextrin

Sponsors

University of Saskatchewan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Minimum of one year of CrossFit experience and doing CrossFit training at least twice a week

Exclusion criteria

* Having consumed beta-alanine in the past six months * Having changed the dose of any other nutritional supplement within the past month * Having suffered a major physical injury in the past six months

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in time to perform a Fran CrossFit workoutBaseline, 3 weeksThis involves alternating sets of dumbbell thrusters and pull-uips

Secondary

MeasureTime frameDescription
Change from baseline in respiratory exchange ratioBaseline, 3 weeksRespiratory exchange ratio (carbon dioxide exhaled relative to oxygen consumed) during the performance test

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026